Anti-Cancer Strategies Using Anaerobic Spore-Forming Bacteria Clostridium: Advances and Synergistic Approaches

Area of Science:

• Oncology
• Microbiology
• Synthetic Biology

Background:

• Cancer remains a major global health challenge with limited treatment efficacy in solid tumors and hypoxic environments.
• Current therapies like chemotherapy and radiation are less effective in these conditions.
• Clostridium-based therapy presents a novel strategy due to its affinity for hypoxic tumor microenvironments.

Purpose of the Study:

• To review the potential of Clostridium-based therapy in cancer treatment.
• To explore its mechanisms including direct tumor lysis, immune modulation, and synergistic effects.
• To discuss advancements in synthetic biology enhancing Clostridium's therapeutic capabilities.

Main Methods:

• Review of preclinical and clinical studies on Clostridium-based cancer treatments.
• Examination of synthetic biology advancements for genetic modification of Clostridium.
• Analysis of direct tumor lysis, immune modulation, and combination therapy approaches.

Main Results:

• Clostridium-based therapy demonstrates unique efficacy in hypoxic solid tumors.
• Genetic modifications, such as alpha toxin gene removal in Clostridium novyi-NT, reduce toxicity and improve targeting.
• Combination therapies show promise for complete cancer eradication in preclinical and clinical studies.

Conclusions:

• Clostridium-based therapy is a promising strategy for solid tumor treatment.
• Synthetic biology advancements enhance the safety and efficacy of Clostridium-based treatments.
• Integrating Clostridium-based therapy with other methods may lead to future cancer eradication.